2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Autism Spectrum Disorder in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xing, X | 1 |
| Zhang, J | 1 |
| Wu, K | 1 |
| Cao, B | 1 |
| Li, X | 1 |
| Jiang, F | 1 |
| Hu, Z | 1 |
| Xia, K | 1 |
| Li, JD | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Autism Spectrum Disorder
| Article | Year |
|---|---|
Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice.
Topics: Animals; Autism Spectrum Disorder; Chromones; Disease Models, Animal; Hippocampus; Humans; Hyperkine | 2019 |